查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566909

靜脈水化治療市場：按服務、按成分、按最終用戶：2024-2033 年全球機會分析和產業預測

Intravenous Hydration Therapy Market By Service, By Component By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 220 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

靜脈（IV）水化治療市場

2023 年，靜脈 (IV) 水化療法市場價值為 23 億美元，預計 2024 年至 2033 年複合年成長率為 7.8%，到 2033 年將達到 49 億美元。

靜脈 (IV) 水合療法是一種透過靜脈將藥物、液體、維生素和電解質直接注入血液的醫療程序。這種療法是一種非常有效的治療方法，因為它可以有效、快速地補充因脫水而損失的必需液體和營養素。脫水是指由於某些疾病、過量飲酒、劇烈運動等導致體內多餘水分流失。這種治療方法可應用於多種醫療環境，包括慢性病的管理、術前和術後護理以及嚴重感染疾病和胃腸道疾病患者的治療。

靜脈（IV）水化療法市場的主要促進因素之一是高壓力人群生活方式的日益激烈。生活壓力大是個人脫水加劇的最常見原因之一。此外，世界各地的老齡化人口正在迅速增加，老年人口更容易生病和住院。這推動了對靜脈水化療法的需求並促進了市場成長。如今，靜脈補水療法作為自我護理和恢復活力的一部分非常流行，尤其是在名人中。此外，還建立了一個名為「水合吧」的專門中心，接受治療作為放鬆的一部分。

然而，其他水合療法（例如口服補液溶液）的可用性正在限制市場開拓。此外，缺乏專用的醫療設施和訓練有素的工作人員，特別是在農村地區，為市場擴張帶來了挑戰。相反，治療期間使用的傳統製劑的技術進步和改進正在為市場成長提供有利可圖的機會。例如，根據每個人的願望開發個人化解決方案，幫助他們實現健康目標。

按部門審查

靜脈水化治療市場分為服務、組件、最終用戶和地區。依服務分類，市場分為免疫增強劑、能量增強劑、護膚、偏頭痛等。從成分來看，分為藥用和非藥用。依最終用戶分類，可分為醫院和診所、健康中心和水療中心、家庭醫療保健等。從區域來看，我們對北美、歐洲、亞太地區和拉丁美洲地區進行了分析。

主要發現

從服務來看，免疫增強劑佔據市場主導地位。

從成分來看，醫藥領域在市場上獲得了巨大的需求。

從最終用戶來看，醫院和診所所佔佔有率較高。

按地區分類，北美領先市場。

該報告可以客製化（需要單獨的費用和時間表）。

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 贖回場景

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章靜脈水化治療市場：依服務分類

  • 市場概況
  • 免疫增強劑
  • 能量助推器
  • 護膚
  • 偏頭痛
  • 其他

第5章靜脈水化治療市場：依組成部分

  • 市場概況
  • 藥用
  • 非藥用的

第6章靜脈水化治療市場：依最終使用者分類

  • 市場概況
  • 醫院診所
  • 健康中心/水療中心
  • 家庭保健
  • 其他

第7章靜脈水化治療市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國靜脈 (IV) 水化治療市場
    • 加拿大靜脈水化治療市場
    • 墨西哥靜脈水化治療市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國靜脈水化治療市場
    • 德國靜脈水化治療市場
    • 義大利靜脈水化治療市場
    • 西班牙靜脈水化治療市場
    • 英國靜脈水化治療市場
    • 其他歐洲國家靜脈水化治療市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國靜脈水化治療市場
    • 日本靜脈水化療法市場
    • 印度靜脈水化治療市場
    • 韓國靜脈水化治療市場
    • 澳洲靜脈水化治療市場
    • 其他亞太地區靜脈水化治療市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西靜脈水化治療市場
    • 南非靜脈水化治療市場
    • 沙烏地阿拉伯靜脈水化治療市場
    • 其他拉丁美洲/中東/非洲靜脈水化治療市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • Davita
  • Nikkiso Co. Ltd.
  • Core IV Therapy, LLC
  • Cryojuvenate UK Ltd.
  • B. Braun Medical Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • NexGen Health
  • JW Life Science Corporation
  • Amanta Healthcare Limited.
  • Baxter International Inc.
簡介目錄
Product Code: A323708

Intravenous (IV) Hydration Therapy Market

The intravenous (IV) hydration therapy market was valued at $2.3 billion in 2023 and is projected to reach $4.9 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

Intravenous (IV) hydration therapy is the medical procedure in which medications, fluids, vitamins, and electrolytes are infused directly into the bloodstream through a vein. The therapy is a highly effective procedure as it ensures efficient and quick replenishment of essential fluids and nutrients lost due to dehydration. Dehydration is the excessive loss of fluids from the body caused by some illness, excessive alcohol consumption, or intense physical activity. The treatment is applicable in diverse medical settings for the management of chronic conditions, preoperative & postoperative care, and to cure patients with severe infections or gastrointestinal problems.

One of the key drivers of the intravenous (IV) hydration therapy market is increase in uptight lifestyle among individuals with high stress levels. A stressed lifestyle is one of the most common reasons for rising dehydration among individuals. In addition, the geriatric population is growing exponentially across the globe, who are highly susceptible to ailments and hospitalization. This boosts the demand for IV hydration therapy, thus augmenting the market growth. In recent times, the administration of IV therapy as a part of self-care routine or rejuvenation is trending, particularly among celebrities. Moreover, specialized centers called "hydration bars" are being established for people to receive therapy as a form of relaxation.

However, the availability of other alternatives for hydration therapy, such as the oral rehydration solutions restrain the development of the market. Furthermore, the shortage of dedicated medical facilities and well-trained staff, particularly in rural areas, presents challenges for the expansion of the market. On the contrary, advancements in technology and modifications in the conventional formulations administered during treatment are presenting lucrative opportunities for market growth. For instance, personalized solutions are being developed according to the requirements of every individual, hence aiding them to achieve their health goal.

Segment Review

The intravenous (IV) hydration therapy market is segmented into service, component, end user, and region. On the basis of service, the market is divided into immune boosters, energy boosters, skin care, migraine, and others. By component, it is bifurcated into medicated and non-medicated. As per end user, it is categorized into hospital & clinics, wellness centers & spas, home healthcare, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of service, the immune boosters segment dominates the market.

By component, the medicated segmented experiences significant demand in the market.

As per end user, the hospital & clinics segment acquires a high share of the market.

Region wise, North America leads the market.

Competition Analysis

The major players operating in the global intravenous (IV) hydration therapy market include Davita, Nikkiso Co. Ltd., Core IV Therapy, LLC, Cryojuvenate UK Ltd., B. Braun Medical Inc., Otsuka Pharmaceutical Co., Ltd., NexGen Health, JW Life Science Corporation, Amanta Healthcare Limited., and Baxter International Inc. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • Reimbursement Scenario

Key Market Segments

By Service

  • Immune boosters
  • Energy boosters
  • Skin care
  • Migraine
  • Others

By Component

  • Medicated
  • Non-medicated

By End User

  • Hospital clinics
  • Wellness centers spas
  • Home healthcare
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Davita
    • Nikkiso Co. Ltd.
    • Core IV Therapy, LLC
    • Cryojuvenate UK Ltd.
    • B. Braun Medical Inc.
    • Otsuka Pharmaceutical Co., Ltd.
    • NexGen Health
    • JW Life Science Corporation
    • Amanta Healthcare Limited.
    • Baxter International Inc.?

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY SERVICE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Service
  • 4.2. Immune Boosters
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Energy Boosters
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Skin Care
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Migraine
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Others
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY COMPONENT

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Component
  • 5.2. Medicated
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Non-medicated
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospital Clinics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Wellness Centers Spas
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Home Healthcare
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Others
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Service
    • 7.2.3. Market Size and Forecast, By Component
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Intravenous (IV) Hydration Therapy Market
      • 7.2.6.1. Market Size and Forecast, By Service
      • 7.2.6.2. Market Size and Forecast, By Component
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Intravenous (IV) Hydration Therapy Market
      • 7.2.7.1. Market Size and Forecast, By Service
      • 7.2.7.2. Market Size and Forecast, By Component
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Intravenous (IV) Hydration Therapy Market
      • 7.2.8.1. Market Size and Forecast, By Service
      • 7.2.8.2. Market Size and Forecast, By Component
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Service
    • 7.3.3. Market Size and Forecast, By Component
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Intravenous (IV) Hydration Therapy Market
      • 7.3.6.1. Market Size and Forecast, By Service
      • 7.3.6.2. Market Size and Forecast, By Component
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Intravenous (IV) Hydration Therapy Market
      • 7.3.7.1. Market Size and Forecast, By Service
      • 7.3.7.2. Market Size and Forecast, By Component
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Intravenous (IV) Hydration Therapy Market
      • 7.3.8.1. Market Size and Forecast, By Service
      • 7.3.8.2. Market Size and Forecast, By Component
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Intravenous (IV) Hydration Therapy Market
      • 7.3.9.1. Market Size and Forecast, By Service
      • 7.3.9.2. Market Size and Forecast, By Component
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Intravenous (IV) Hydration Therapy Market
      • 7.3.10.1. Market Size and Forecast, By Service
      • 7.3.10.2. Market Size and Forecast, By Component
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Intravenous (IV) Hydration Therapy Market
      • 7.3.11.1. Market Size and Forecast, By Service
      • 7.3.11.2. Market Size and Forecast, By Component
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Service
    • 7.4.3. Market Size and Forecast, By Component
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Intravenous (IV) Hydration Therapy Market
      • 7.4.6.1. Market Size and Forecast, By Service
      • 7.4.6.2. Market Size and Forecast, By Component
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Intravenous (IV) Hydration Therapy Market
      • 7.4.7.1. Market Size and Forecast, By Service
      • 7.4.7.2. Market Size and Forecast, By Component
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Intravenous (IV) Hydration Therapy Market
      • 7.4.8.1. Market Size and Forecast, By Service
      • 7.4.8.2. Market Size and Forecast, By Component
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Intravenous (IV) Hydration Therapy Market
      • 7.4.9.1. Market Size and Forecast, By Service
      • 7.4.9.2. Market Size and Forecast, By Component
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Intravenous (IV) Hydration Therapy Market
      • 7.4.10.1. Market Size and Forecast, By Service
      • 7.4.10.2. Market Size and Forecast, By Component
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Intravenous (IV) Hydration Therapy Market
      • 7.4.11.1. Market Size and Forecast, By Service
      • 7.4.11.2. Market Size and Forecast, By Component
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Service
    • 7.5.3. Market Size and Forecast, By Component
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Intravenous (IV) Hydration Therapy Market
      • 7.5.6.1. Market Size and Forecast, By Service
      • 7.5.6.2. Market Size and Forecast, By Component
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Intravenous (IV) Hydration Therapy Market
      • 7.5.7.1. Market Size and Forecast, By Service
      • 7.5.7.2. Market Size and Forecast, By Component
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Intravenous (IV) Hydration Therapy Market
      • 7.5.8.1. Market Size and Forecast, By Service
      • 7.5.8.2. Market Size and Forecast, By Component
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Intravenous (IV) Hydration Therapy Market
      • 7.5.9.1. Market Size and Forecast, By Service
      • 7.5.9.2. Market Size and Forecast, By Component
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Davita
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Nikkiso Co. Ltd.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Core IV Therapy, LLC
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Cryojuvenate UK Ltd.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. B. Braun Medical Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Otsuka Pharmaceutical Co., Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. NexGen Health
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. JW Life Science Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Amanta Healthcare Limited.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Baxter International Inc.?
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments